Paratek Pharmaceuticals Overview

Life ScienceCompany

Is Paratek Pharmaceuticals PE-backed?

Yes. Paratek Pharmaceuticals is owned by private equity investors Gurnet Point Capital and Novo Holdings A/S.

Was Paratek Pharmaceuticals formerly PE-backed?

Yes. Paratek Pharmaceuticals was formerly owned by 1 private investor.

Where is Paratek Pharmaceuticals headquartered?

Paratek Pharmaceuticals is headquartered in King of Prussia, Pennsylvania.

What is Paratek Pharmaceuticals’ revenue?

Paratek Pharmaceuticals disclosed revenue of 47M USD for 2020 and 17M USD for 2019.

How many employees does Paratek Pharmaceuticals have?

Paratek Pharmaceuticals has 101 employees.

What sector is Paratek Pharmaceuticals in?

Paratek Pharmaceuticals is a life science company.

When was Paratek Pharmaceuticals founded?

Paratek Pharmaceuticals was founded in 1996.

Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc.

1000 First Avenue Suite 200,
King of Prussia, Pennsylvania 19406
United States,
(617) 807-6600
www.paratekpharma.com

Paratek Pharmaceuticals is a bio-pharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek Pharmaceuticals was founded in 1996 and is based in King of Prussia, Pennsylvania.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 1 - - - - 1 2
vol $330M $330M
Sell (0.0/yr) # - - - - - - 0
  2

Top M&A Advisors

Financial Deals
Lazard
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
1

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.